메뉴 건너뛰기




Volumn 17, Issue 1, 2011, Pages 77-79

Refractory bulbar and respiratory dysfunction in a young Chinese woman with seronegative, muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Response to cyclophosphamide and rituximab treatment

Author keywords

Cyclophosphamide; Muscular atrophy; Myasthenia gravis; Receptor proteintyrosine kinases

Indexed keywords

ANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; NADROPARIN; PREDNISOLONE; PYRIDOSTIGMINE; RITUXIMAB; UNCLASSIFIED DRUG; WARFARIN;

EID: 79951468795     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (9)
  • 1
    • 33344468696 scopus 로고    scopus 로고
    • Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization
    • Ip MS, Ko FW, Lau AC, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest 2006;129:384-92.
    • (2006) Chest , vol.129 , pp. 384-392
    • Ip, M.S.1    Ko, F.W.2    Lau, A.C.3
  • 2
    • 64349115066 scopus 로고    scopus 로고
    • Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity
    • Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009;8:475-90.
    • (2009) Lancet Neurol , vol.8 , pp. 475-490
    • Meriggioli, M.N.1    Sanders, D.B.2
  • 4
    • 33644528477 scopus 로고    scopus 로고
    • High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies
    • Lin PT, Martin BA, Weinacker AB, So YT. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies. Muscle Nerve 2006;33:433-5.
    • (2006) Muscle Nerve , vol.33 , pp. 433-435
    • Lin, P.T.1    Martin, B.A.2    Weinacker, A.B.3    So, Y.T.4
  • 5
    • 4644352009 scopus 로고    scopus 로고
    • Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma
    • Gajra A, Vajpayee N, Grethlein SJ. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. Am J Hematol 2004;77:196-7.
    • (2004) Am J Hematol , vol.77 , pp. 196-197
    • Gajra, A.1    Vajpayee, N.2    Grethlein, S.J.3
  • 7
    • 68549085230 scopus 로고    scopus 로고
    • Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review
    • Nelson RP Jr, Pascuzzi RM, Kessler K, et al. Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review. J Clin Neuromuscul Dis 2009;10:170-7.
    • (2009) J Clin Neuromuscul Dis , vol.10 , pp. 170-177
    • Nelson Jr., R.P.1    Pascuzzi, R.M.2    Kessler, K.3
  • 9
    • 44949109211 scopus 로고    scopus 로고
    • Steroids and immunosuppressant drugs in myasthenia gravis
    • Sathasivam S. Steroids and immunosuppressant drugs in myasthenia gravis. Nat Clin Pract Neurol 2008;4:317-27.
    • (2008) Nat Clin Pract Neurol , vol.4 , pp. 317-327
    • Sathasivam, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.